Related Experiment Video
Updated: Feb 5, 2026

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed mice
Eliciane Cevolani Mattos1, Kaustav Das Gupta1, Derek Quintanilla1
1Division of Infectious Disease, The Lundquist Institute for Biomedical Innovation at Harbor-University of California, Los Angeles Medical Center, Torrance, CA, United States.
Introduction:
Candida auris is an emerging, multidrug-resistant fungal pathogen associated with high mortality in immunocompromised individuals. Resistance to current antifungal drugs emphasizes the need for new therapeutic approaches. We investigated granulocyte-macrophage colony-stimulating factor (GM-CSF) as a standalone immunotherapy and in combination with a sub-therapeutic dose of micafungin in an immunosuppressed mouse model of systemic C. auris infection.
Methods:
Immunosuppressed ICR CD-1 mice (4-6 weeks old) were infected with C. auris and treated daily via intraperitoneal injection with PBS (placebo), murine GM-CSF (0.2 or 2 μg), micafungin, or both. Treatments began 24 h post-infection and continued through day 4 (GM-CSF) or day 7 (micafungin). Survival, tissue fungal burden, histopathology, and immune cell frequencies in spleen and kidneys were assessed. GM-CSF effects on neutrophil and macrophage antifungal functions were evaluated in ex vivo assays.
Results:
GM-CSF monotherapy significantly improved survival (30-32% vs. 0% in controls), extended median survival time, and reduced fungal burden in the kidney, heart, and brain. Although the combination therapy yielded the highest survival rate, it did not differ significantly from GM-CSF alone. Histopathological examination confirmed decreased fungal load and tissue damage in GM-CSF-treated mice. Additionally, GM-CSF augmented macrophage and neutrophil populations in spleen and kidney, enhanced fungal uptake and killing via reactive oxygen species and neutrophil extracellular traps.
Discussion:
GM-CSF augments antifungal immunity and represents a promising adjunctive immunotherapy against MDR C. auris infection.
Insights
Granulocyte-macrophage colony-stimulating factor (GM-CSF) immunotherapy improved survival and reduced fungal burden in mice with multidrug-resistant Candida auris infection. GM-CSF shows promise as an adjunctive therapy against this serious fungal pathogen.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Candida auris is a multidrug-resistant fungus causing high mortality in immunocompromised individuals.
- Existing antifungal drugs are becoming less effective, necessitating novel therapeutic strategies.
- The need for alternative treatments against emerging fungal pathogens like C. auris is critical.
Purpose of the Study:
- To investigate granulocyte-macrophage colony-stimulating factor (GM-CSF) as a potential immunotherapy for systemic C. auris infection.
- To evaluate GM-CSF as a standalone treatment and in combination with micafungin.
- To assess the efficacy of GM-CSF in an immunosuppressed mouse model.
Main Methods:
- Immunosuppressed mice were infected with C. auris.
- Mice received daily intraperitoneal injections of PBS, GM-CSF, micafungin, or a combination.
- Survival, fungal burden, histopathology, and immune cell changes were analyzed.
- Ex vivo assays assessed GM-CSF's impact on neutrophil and macrophage functions.
Main Results:
- GM-CSF monotherapy significantly improved survival rates and extended survival time compared to controls.
- GM-CSF treatment reduced fungal burden in multiple organs, including the kidney, heart, and brain.
- GM-CSF enhanced immune cell populations and augmented antifungal functions of neutrophils and macrophages.
Conclusions:
- GM-CSF demonstrates significant antifungal properties against multidrug-resistant C. auris.
- GM-CSF acts by augmenting innate immune cell responses.
- GM-CSF represents a promising adjunctive immunotherapy for C. auris infections.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Defenses Against Pathogens and Herbivores
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Gene Therapy
Second Order systems II

